Form 483

Invitro Research Solutions Private Ltd Form 483, 2025-12-18

FDA issued a Form 483 to Invitro Research Solutions Private Ltd on 2025-12-18 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Invitro Research Solutions Private Ltd · Bengaluru, India · Issued December 18, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Dec 2025
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Zachary L Stamm

18 Dec 2025
21 CFR 211.166(a)(3)

Valid stability test methods

Cited by Zachary L Stamm

18 Dec 2025
21 CFR 211.192

Written record of investigation incomplete

Cited by Zachary L Stamm

18 Dec 2025
21 CFR 211.194(a)

Complete test data included in records

Cited by Zachary L Stamm

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere